Company Profile

Pieris is a clinical-stage biotechnology company that combines leading protein engineering capabilities and deep understanding into molecular drivers of disease to develop medicines that drive local biology to produce superior clinical outcomes for patients. Our pipeline includes inhalable Anticalin proteins to treat respiratory diseases and locally-activated bispecifics for immuno-oncology. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by respiratory and immuno-oncology focused partnerships with leading pharmaceutical companies.

Latest Presentation

Industry Classifications

Sector:
Healthcare

Industry:
Biotechnology

NAICS:
Research and Development in Biotechnology (541711)

SIC:
Commercial Physical and Biological Research (8731)

Contact Information

Investor Relations
Maria Kelman
Executive Director, Investor Relations
T: +1-857-327-7631
kelman@pieris.com

Company Contact
Pieris Pharmaceuticals, Inc.
255 State Street, 9th floor
Boston, MA 02109
USA
T: + 1 (857) 246-8998
info@pieris.com